New pharmacological options in patients with atrial fibrillation: The ATHENA trial;Nuevas perspectivas farmacológicas en pacientes con fibrilación auricular: El ensayo ATHENA

Revista Espanola de Cardiologia

Volumn 62, Issue 5, 2009, Pages 479-481

  Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CANDESARTAN; DRONEDARONE; ANTIARRHYTHMIC AGENT; DRUG DERIVATIVE;

CATHETER ABLATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM MUSCLE; HEART FAILURE; KIDNEY FUNCTION; MORBIDITY; MORTALITY; PREVALENCE; PRIMARY PREVENTION; RABBIT; RISK FACTOR; STROKE; BIOASSAY; HUMAN; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ENDPOINT DETERMINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 68049147567     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)71027-9     Document Type: Editorial

References (15)

1. A.S. Go, E.M. Hylek, K.A. Philips, Y. Chang, L.E. Henault, and J.V. Selby Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention; the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
2. P.A. Wolf, J.B. Mitchell, C.S. Baker, W.B. Kannel, and R.B. D'Agostino Impact of atrial fibrillation on mortality, stroke, and medical costs Arch Intern Med 158 1998 229 234
3. W.A. Wattigney, G.A. Mensah, and J.B. Croft Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 trough 1999: Implications for primary prevention Circulation 108 2003 711 716
4. D.D. Spragg, D. Dalal, A. Cheema, D. Scherr, K. Chilukuri, and A. Cheng Complications of catheter ablation for atrial fibrillation: Incidence and predictors J Cardiovasc Electrophysiol 19 2008 627 631
5. W. Sun, J.S.M. Sarma, and B.N. Singh Electrophysiological effects of dronedarone (SR33589), a non-iodinated benzofuran derivative in the rabbit heart. Comparison with amiodarone Circulation 100 1999 2276 2281
6. W. Sun, J.S.M. Sarma, and B.N. Singh Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone J Cardiovasc Pharmacol 39 2002 677 684
7. F.T. Wegener, J.R. Ehrlich, and S.H. Hohnloser Dronedarone: an emerging agent with rhythm- and rate-controlling effects J Cardiovasc Electrophysiol 17 2006 S17 S20
8. S.H. Hohnloser, H.J.G.M. Crijns, M. Van Eickels, C. Gaudin, R.L. Page, and C. Torp-Pedersen Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
9. B.N. Singh, S.J. Connolly, H.J. Crijns, D. Roy, P.R. Kowey, A. Capucci EURIDIS and ADONIS Investigators Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 2007 987 999
10. J.M. Davy, M. Herold, C. Hoglund, A. Timmermans, A. Alings, D. Radzik The ERATO Study Investigators Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study Am Heart J 156 2008 527.e1 527.e9
11. L. Kober, C. Torp-Pedersen, J.J. McMurray, O. Gøtzsche, S. Lévy, and H. Crijns Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
12. S.D. Solomon, J. Dobson, S. Pocock, H. Skali, J.J. McMurray, C.B. Granger Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure Circulation 116 2007 1482 1487
13. Y. Tschuppert, T. Buclin, L.E. Rothuizen, L.A. Decosterd, J. Galleyrand, and C. Gaud Effect of dronedarone on renal function in healthy subjects Br J Clin Pharmacol 64 2007 785 791
14. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
15. D. Roy, M. Talajic, S. Nattel, D.G. Wyse, P. Dorian, and K.L. Lee Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677